R. Roßkamp

979 total citations
32 papers, 654 citations indexed

About

R. Roßkamp is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, R. Roßkamp has authored 32 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in R. Roßkamp's work include Growth Hormone and Insulin-like Growth Factors (9 papers), Diabetes Management and Research (8 papers) and Metabolism and Genetic Disorders (4 papers). R. Roßkamp is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (9 papers), Diabetes Management and Research (8 papers) and Metabolism and Genetic Disorders (4 papers). R. Roßkamp collaborates with scholars based in Germany, United States and United Kingdom. R. Roßkamp's co-authors include Karin Wernicke‐Panten, Elke Schüler, F. Haverkamp, Michael Becker, P. D. Home, Anastasia Dressler, Lutz Heinemann, Tim Heise, Klaus Zerres and Kenneth S. Hershon and has published in prestigious journals such as Diabetes, Journal of the American Society of Nephrology and Journal of Bone and Mineral Research.

In The Last Decade

R. Roßkamp

29 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Roßkamp Germany 14 413 205 193 136 95 32 654
Tanny Tsao United States 12 176 0.4× 209 1.0× 91 0.5× 53 0.4× 81 0.9× 27 534
Минара Шамхаловна Шамхалова Russia 11 353 0.9× 191 0.9× 172 0.9× 83 0.6× 44 0.5× 86 618
Elsa P. Paulsen United States 11 201 0.5× 116 0.6× 154 0.8× 120 0.9× 52 0.5× 23 510
Herbert Gershberg United States 16 363 0.9× 152 0.7× 106 0.5× 164 1.2× 50 0.5× 40 744
Rosemarie Lajara United States 14 615 1.5× 313 1.5× 192 1.0× 231 1.7× 17 0.2× 22 815
M. T. Chau China 11 243 0.6× 188 0.9× 168 0.9× 35 0.3× 23 0.2× 20 652
Norihisa Osawa Japan 10 212 0.5× 128 0.6× 122 0.6× 58 0.4× 56 0.6× 14 495
Kirk Siddals United Kingdom 13 312 0.8× 287 1.4× 105 0.5× 65 0.5× 31 0.3× 31 616
D. L. Russell-Jones United Kingdom 15 471 1.1× 194 0.9× 107 0.6× 71 0.5× 64 0.7× 24 735
Trevor H. Thomas United Kingdom 14 113 0.3× 198 1.0× 55 0.3× 73 0.5× 120 1.3× 29 539

Countries citing papers authored by R. Roßkamp

Since Specialization
Citations

This map shows the geographic impact of R. Roßkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Roßkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Roßkamp more than expected).

Fields of papers citing papers by R. Roßkamp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Roßkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Roßkamp. The network helps show where R. Roßkamp may publish in the future.

Co-authorship network of co-authors of R. Roßkamp

This figure shows the co-authorship network connecting the top 25 collaborators of R. Roßkamp. A scholar is included among the top collaborators of R. Roßkamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Roßkamp. R. Roßkamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ariceta, Gema, Kelly Barrios, Bob D. Brown, et al.. (2021). Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria. Kidney International Reports. 6(4). 1088–1098. 30 indexed citations
2.
Roberts, Mary Scott, Rachel I. Gafni, Beth A Brillante, et al.. (2019). Treatment of Autosomal Dominant Hypocalcemia Type 1 With the Calcilytic NPSP795 (SHP635). Journal of Bone and Mineral Research. 34(9). 1609–1618. 31 indexed citations
3.
Dellweg, Sibylle, Chandra Y. Osborn, Lutz Heinemann, et al.. (2006). Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof‐of‐concept study. Diabetes Obesity and Metabolism. 8(5). 574–580. 10 indexed citations
4.
Home, P. D., et al.. (2005). A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes. Diabetes/Metabolism Research and Reviews. 21(6). 545–553. 56 indexed citations
5.
Hershon, Kenneth S., et al.. (2004). Once-Daily Insulin Glargine Compared with Twice-Daily NPH Insulin in Patients with Type 1 Diabetes. Endocrine Practice. 10(1). 10–17. 34 indexed citations
6.
Heise, Tim, et al.. (2002). No evidence for accumulation of insulin glargine (LANTUS®): a multiple injection study in patients with Type 1 diabetes. Diabetic Medicine. 19(6). 490–495. 48 indexed citations
7.
Roßkamp, R.. (1996). Safety aspects of oral hypoglycaemic agents. Diabetologia. 39(12). 1668–1672. 5 indexed citations
8.
Wernicke‐Panten, Karin, et al.. (1996). Long-Term Treatment of Type 2 Diabetic Patients with the New Oral Antidiabetic Agent Glimepiride (Amaryl®): A Double-Blind Comparison with Glibenclamide. Hormone and Metabolic Research. 28(9). 419–425. 104 indexed citations
9.
Fahnenstich, Hubert, Christof Dame, Axel Alléra, R. Roßkamp, & Sabina Kowalewski. (1995). Erythropoietin als biochemischer Parameter für fetale Hypoxie. Klinische Pädiatrie. 207(6). 326–330. 2 indexed citations
10.
Haverkamp, F., et al.. (1991). Syndrome of developmental retardation, facial and skeletal anomalies, and hyperphosphatasia in two sisters: Nosology and genetics of the coffin‐siris syndrome. American Journal of Medical Genetics. 41(3). 350–354. 27 indexed citations
11.
Roßkamp, R., et al.. (1990). The Effect of Cyproheptadine on Plasma Growth Hormone (GH) and on Somatostatin Response to GH-Releasing Hormone in Man. Hormone and Metabolic Research. 22(5). 295–297. 2 indexed citations
12.
Haverkamp, F., Klaus Zerres, & R. Roßkamp. (1989). Three sibs with achalasia and alacrimia: A separate entity different from triple‐A syndrome. American Journal of Medical Genetics. 34(2). 289–291. 14 indexed citations
13.
Kruse, K., et al.. (1988). Hyperphosphatasia with mental retardation. The Journal of Pediatrics. 112(3). 436–439. 25 indexed citations
14.
Roßkamp, R., et al.. (1988). Plasma growth hormone-releasing hormone levels in type 1 (insulin-dependent) diabetic children following a mixed meal. Journal of Molecular Medicine. 66(6). 257–260. 1 indexed citations
15.
16.
Roßkamp, R., et al.. (1987). Plasma levels of growth hormone-releasing hormone and somatostatin in response to a mixed meal and during sleep in children. European Journal of Endocrinology. 116(4). 549–554. 9 indexed citations
17.
Roßkamp, R.. (1987). Hormonelle Befunde bei adipösen Kindern Übersicht. Klinische Pädiatrie. 199(4). 253–259. 1 indexed citations
18.
Roßkamp, R., et al.. (1987). Insulinhypoglycemia but not Arginine Infusion Stimulates Circulating Plasma Growth Hormone-Releasing Hormone (GHRH) Concentrations in Children. Hormone and Metabolic Research. 19(9). 434–436. 7 indexed citations
19.
Roßkamp, R., et al.. (1987). Idiopathische juvenile Osteoporose - Bericht über zwei Fälle. Klinische Pädiatrie. 199(6). 457–461. 1 indexed citations
20.
Ranke, MB, R. Roßkamp, Andrea Attanasio, et al.. (1984). Estrogens promote growth: Experimental and clinical evidence. Pediatric Research. 18(11). 1209–1209. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tanny Tsao Breakdown of academic impact, for papers by Минара Шамхаловна Шамхалова Breakdown of academic impact, for papers by Elsa P. Paulsen Breakdown of academic impact, for papers by Herbert Gershberg Breakdown of academic impact, for papers by Rosemarie Lajara Breakdown of academic impact, for papers by M. T. Chau Breakdown of academic impact, for papers by Norihisa Osawa Breakdown of academic impact, for papers by Kirk Siddals Breakdown of academic impact, for papers by D. L. Russell-Jones Breakdown of academic impact, for papers by Trevor H. Thomas
Rankless by CCL
2026